A phase 2, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of orally administered VT-1161 in the treatment of recurrent vulvovaginal candidiasis

Autor: Brand, Stephen R., Degenhardt, Thorsten P., Person, Karen, Sobel, Jack D., Nyirjesy, Paul, Schotzinger, Robert J., Tavakkol, Amir
Zdroj: In American Journal of Obstetrics and Gynecology June 2018 218(6):624-624
Databáze: ScienceDirect
Externí odkaz: